{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:19:20Z","timestamp":1792685960429,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,3,27]],"date-time":"2019-03-27T00:00:00Z","timestamp":1553644800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["1731340-2"],"award-info":[{"award-number":["1731340-2"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12957-019-1595-7","type":"journal-article","created":{"date-parts":[[2019,3,27]],"date-time":"2019-03-27T18:29:54Z","timestamp":1553711394000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["Clinical outcome of cerebrospinal fluid shunts in patients with leptomeningeal carcinomatosis"],"prefix":"10.1186","volume":"17","author":[{"given":"Hye Seon","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Bae","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho-Shin","family":"Gwak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Woong","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Hoon","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heon","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,27]]},"reference":[{"key":"1595_CR1","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1634\/theoncologist.2008-0138","volume":"13","author":"MC Chamberlain","year":"2008","unstructured":"Chamberlain MC. Neoplastic meningitis. Oncologist. 2008;13:967\u201377.","journal-title":"Oncologist"},{"key":"1595_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3340\/jkns.2015.58.1.1","volume":"58","author":"HS Gwak","year":"2015","unstructured":"Gwak HS, Lee SH, Park WS, et al. Recent advancements of treatment for leptomeningeal carcinomatosis. J Korean Neurosurg Soc. 2015;58:1\u20138.","journal-title":"J Korean Neurosurg Soc"},{"key":"1595_CR3","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1097\/JTO.0b013e3182398e4f","volume":"7","author":"PG Morris","year":"2012","unstructured":"Morris PG, Reiner AS, Szenberg OR, et al. Leptomeningeal metastasis from non-small cell lung cancer: survival and the impact of whole brain radiotherapy. J Thorac Oncol. 2012;7:382\u20135.","journal-title":"J Thorac Oncol"},{"key":"1595_CR4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s002800000118","volume":"46","author":"ML Tetef","year":"2000","unstructured":"Tetef ML, Margolin KA, Doroshow JH, et al. Pharmacokinetics and toxicity of high-dose intravenous methotrexate in the treatment of leptomeningeal carcinomatosis. Cancer Chemother Pharmacol. 2000;46:19\u201326.","journal-title":"Cancer Chemother Pharmacol"},{"key":"1595_CR5","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1056\/NEJM197507242930402","volume":"293","author":"WR Shapiro","year":"1975","unstructured":"Shapiro WR, Young DF, Mehta BM. Methotrexate: distribution in cerebrospinal fluid after intravenous, ventricular and lumbar injections. N Engl J Med. 1975;293:161\u20136.","journal-title":"N Engl J Med"},{"key":"1595_CR6","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1002\/1097-0142(19820215)49:4<759::AID-CNCR2820490427>3.0.CO;2-7","volume":"49","author":"WR Wasserstrom","year":"1982","unstructured":"Wasserstrom WR, Glass JP, Posner JB. Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients. Cancer. 1982;49:759\u201372.","journal-title":"Cancer"},{"key":"1595_CR7","doi-asserted-by":"publisher","first-page":"2726","DOI":"10.1016\/j.ejca.2004.08.012","volume":"40","author":"W Boogerd","year":"2004","unstructured":"Boogerd W, van den Bent MJ, Koehler PJ, et al. The relevance of intraventricular chemotherapy for leptomeningeal metastasis in breast cancer: a randomised study. Eur J Cancer. 2004;40:2726\u201333.","journal-title":"Eur J Cancer"},{"key":"1595_CR8","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1002\/(SICI)1097-0142(19980501)82:9<1764::AID-CNCR24>3.0.CO;2-1","volume":"82","author":"F Bokstein","year":"1998","unstructured":"Bokstein F, Lossos A, Siegal T. Leptomeningeal metastases from solid tumors: a comparison of two prospective series treated with and without intra-cerebrospinal fluid chemotherapy. Cancer. 1998;82:1756\u201363.","journal-title":"Cancer"},{"key":"1595_CR9","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1023\/A:1005982826121","volume":"38","author":"MC Chamberlain","year":"1998","unstructured":"Chamberlain MC. Radioisotope CSF flow studies in leptomeningeal metastases. J Neuro-Oncol. 1998;38:135\u201340.","journal-title":"J Neuro-Oncol"},{"key":"1595_CR10","first-page":"633","volume":"61","author":"RG Blasberg","year":"1977","unstructured":"Blasberg RG, Patlak CS, Shapiro WR. Distribution of methotrexate in the cerebrospinal fluid and brain after intraventricular administration. Cancer Treat Rep. 1977;61:633\u201341.","journal-title":"Cancer Treat Rep"},{"key":"1595_CR11","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.clineuro.2014.01.023","volume":"119","author":"TY Jung","year":"2014","unstructured":"Jung TY, Chung WK, Oh IJ. The prognostic significance of surgically treated hydrocephalus in leptomeningeal metastases. Clin Neurol Neurosurg. 2014;119:80\u20133.","journal-title":"Clin Neurol Neurosurg"},{"key":"1595_CR12","doi-asserted-by":"publisher","first-page":"730","DOI":"10.3171\/2011.5.JNS101768","volume":"115","author":"N Lin","year":"2011","unstructured":"Lin N, Dunn IF, Glantz M, et al. Benefit of ventriculoperitoneal cerebrospinal fluid shunting and intrathecal chemotherapy in neoplastic meningitis: a retrospective, case-controlled study. J Neurosurg. 2011;115:730\u20136.","journal-title":"J Neurosurg"},{"key":"1595_CR13","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s11060-010-0512-2","volume":"104","author":"SH Lee","year":"2011","unstructured":"Lee SH, Kong DS, Seol HJ, et al. Ventriculoperitoneal shunt for hydrocephalus caused by central nervous system metastasis. J Neuro-Oncol. 2011;104:545\u201351.","journal-title":"J Neuro-Oncol"},{"key":"1595_CR14","doi-asserted-by":"publisher","first-page":"562","DOI":"10.3171\/jns.1976.44.5.0562","volume":"44","author":"HJ Hoffman","year":"1976","unstructured":"Hoffman HJ, Hendrick EB, Humphreys RP. Metastasis via ventriculoperitoneal shunt in patients with medulloblastoma. J Neurosurg. 1976;44:562\u20136.","journal-title":"J Neurosurg"},{"key":"1595_CR15","doi-asserted-by":"publisher","first-page":"E4","DOI":"10.3171\/2014.8.FOCUS14436","volume":"37","author":"RP Menger","year":"2014","unstructured":"Menger RP, Connor DE Jr, Thakur JD, et al. A comparison of lumboperitoneal and ventriculoperitoneal shunting for idiopathic intracranial hypertension: an analysis of economic impact and complications using the Nationwide Inpatient Sample. Neurosurg Focus. 2014;37:E4.","journal-title":"Neurosurg Focus"},{"key":"1595_CR16","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/ana.410380111","volume":"38","author":"RJ Freilich","year":"1995","unstructured":"Freilich RJ, Krol G, DeAngelis LM. Neuroimaging and cerebrospinal fluid cytology in the diagnosis of leptomeningeal metastasis. Ann Neurol. 1995;38:51\u20137.","journal-title":"Ann Neurol"},{"key":"1595_CR17","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1097\/JTO.0b013e318287c943","volume":"8","author":"HS Gwak","year":"2013","unstructured":"Gwak HS, Joo J, Kim S, et al. Analysis of treatment outcomes of intraventricular chemotherapy in 105 patients for leptomeningeal carcinomatosis from non-small-cell lung cancer. J Thorac Oncol. 2013;8:599\u2013605.","journal-title":"J Thorac Oncol"},{"key":"1595_CR18","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1097\/00000421-199808000-00010","volume":"21","author":"J Lokich","year":"1998","unstructured":"Lokich J, Levine H, Nasser I. Malignancy-related hydrocephalus: clinical features and results of ventricular peritoneal shunt procedure in three patients. Am J Clin Oncol. 1998;21:366\u20138.","journal-title":"Am J Clin Oncol"},{"key":"1595_CR19","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1212\/01.WNL.0000160396.69050.DC","volume":"64","author":"AM Omuro","year":"2005","unstructured":"Omuro AM, Lallana EC, Bilsky MH, et al. Ventriculoperitoneal shunt in patients with leptomeningeal metastasis. Neurology. 2005;64:1625\u20137.","journal-title":"Neurology"},{"key":"1595_CR20","doi-asserted-by":"publisher","first-page":"627","DOI":"10.3171\/jns.2004.101.4.0627","volume":"101","author":"MJ McGirt","year":"2004","unstructured":"McGirt MJ, Woodworth G, Thomas G, et al. Cerebrospinal fluid shunt placement for pseudotumor cerebri-associated intractable headache: predictors of treatment response and an analysis of long-term outcomes. J Neurosurg. 2004;101:627\u201332.","journal-title":"J Neurosurg"},{"key":"1595_CR21","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3171\/2012.11.JNS111384","volume":"119","author":"TJ Wilson","year":"2013","unstructured":"Wilson TJ, Stetler WR Jr, Al-Holou WN, et al. Comparison of the accuracy of ventricular catheter placement using freehand placement, ultrasonic guidance, and stereotactic neuronavigation. J Neurosurg. 2013;119:66\u201370.","journal-title":"J Neurosurg"},{"key":"1595_CR22","doi-asserted-by":"publisher","first-page":"899","DOI":"10.3171\/2014.3.JNS131088","volume":"121","author":"L Lee","year":"2014","unstructured":"Lee L, King NK, Kumar D, et al. Use of programmable versus nonprogrammable shunts in the management of hydrocephalus secondary to aneurysmal subarachnoid hemorrhage: a retrospective study with cost-benefit analysis. J Neurosurg. 2014;121:899\u2013903.","journal-title":"J Neurosurg"},{"key":"1595_CR23","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1007\/s00701-004-0392-3","volume":"146","author":"K Karabatsou","year":"2004","unstructured":"Karabatsou K, Quigley G, Buxton N, et al. Lumboperitoneal shunts: are the complications acceptable? Acta Neurochir. 2004;146:1193\u20137.","journal-title":"Acta Neurochir"},{"key":"1595_CR24","doi-asserted-by":"publisher","first-page":"872","DOI":"10.3171\/jns.1991.74.6.0872","volume":"74","author":"MS Berger","year":"1991","unstructured":"Berger MS, Baumeister B, Geyer JR, et al. The risks of metastases from shunting in children with primary central nervous system tumors. J Neurosurg. 1991;74:872\u20137.","journal-title":"J Neurosurg"},{"key":"1595_CR25","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1215\/S115285170200042X","volume":"5","author":"PM Magtibay","year":"2003","unstructured":"Magtibay PM, Friedman JA, Rao RD, et al. Unusual presentation of adult metastatic peritoneal medulloblastoma associated with a ventriculoperitoneal shunt: a case study and review of the literature. Neuro-Oncology. 2003;5:217\u201320.","journal-title":"Neuro-Oncology"},{"key":"1595_CR26","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1212\/WNL.46.6.1524","volume":"46","author":"ER Eggenberger","year":"1996","unstructured":"Eggenberger ER, Miller NR, Vitale S. Lumboperitoneal shunt for the treatment of pseudotumor cerebri. Neurology. 1996;46:1524\u201330.","journal-title":"Neurology"},{"key":"1595_CR27","doi-asserted-by":"publisher","first-page":"770","DOI":"10.3171\/jns.1975.43.6.0770","volume":"43","author":"RF Spetzler","year":"1975","unstructured":"Spetzler RF, Wilson CB, Grollmus JM. Percutaneous lumboperitoneal shunt. Technical note. J Neurosurg. 1975;43:770\u20133.","journal-title":"J Neurosurg"},{"key":"1595_CR28","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1227\/00006123-199006000-00013","volume":"26","author":"N Aoki","year":"1990","unstructured":"Aoki N. Lumboperitoneal shunt: clinical applications, complications, and comparison with ventriculoperitoneal shunt. Neurosurgery. 1990;26:998\u20131003 discussion 1003\u20131004.","journal-title":"Neurosurgery"},{"key":"1595_CR29","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.3171\/2010.6.JNS1020","volume":"113","author":"AK Toma","year":"2010","unstructured":"Toma AK, Dherijha M, Kitchen ND, et al. Use of lumboperitoneal shunts with the Strata NSC valve: a single-center experience. J Neurosurg. 2010;113:1304\u20138.","journal-title":"J Neurosurg"},{"key":"1595_CR30","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3171\/PED\/2008\/2\/7\/019","volume":"2","author":"TD Nadkarni","year":"2008","unstructured":"Nadkarni TD, Rekate HL, Wallace D. Concurrent use of a lumboperitoneal shunt with programmable valve and ventricular access device in the treatment of pseudotumor cerebri: review of 40 cases. J Neurosurg Pediatr. 2008;2:19\u201324.","journal-title":"J Neurosurg Pediatr"},{"key":"1595_CR31","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.mehy.2015.02.009","volume":"84","author":"XH Zhang","year":"2015","unstructured":"Zhang XH, Wang XG, Piao YZ, et al. Lumboperitoneal shunt for the treatment of leptomeningeal metastasis. Med Hypotheses. 2015;84:506\u20138.","journal-title":"Med Hypotheses"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-019-1595-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12957-019-1595-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-019-1595-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,26]],"date-time":"2020-03-26T00:14:02Z","timestamp":1585181642000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-019-1595-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,27]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1595"],"URL":"https:\/\/doi.org\/10.1186\/s12957-019-1595-7","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,27]]},"assertion":[{"value":"6 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Institutional Review Board (IRB) of National Cancer Center (NCC2018-0051).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"59"}}